Armistice Capital’s GeoVax Labs GOVX Stock Holding History

Armistice Capital’s Portfolio GOVX Stock Details GOVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-269,253	Closed	-$372K	–	367
2026 Q1	$372K	Buy	+269,253	New	+$645K	0.01%	182
2025 Q4	–	Sell	-21,356	Closed	-$253K	–	422
2025 Q3	$253K	Buy	+21,356	New	+$374K	﹤0.01%	281
2025 Q2	–	Sell	-26,515	Closed	-$703K	–	228
2025 Q1	$703K	Buy	+26,515	New	+$1.17M	0.01%	175
2024 Q3	–	Sell	-3,200	Closed	-$255K	–	288
2024 Q2	$255K	Sell	3,200 -3,920	-55%	-$172K	﹤0.01%	197
2024 Q1	$356K	Buy	7,120 +2,783	+64%	+$220K	﹤0.01%	231
2023 Q4	$587K	Buy	+4,337	New	+$759K	0.01%	194
2022 Q3	–	Sell	-3,623	Closed	-$1.13M	–	218
2022 Q2	$1.13M	Buy	3,623 +2,463	+212%	+$1.09M	0.02%	125
2022 Q1	$500K	Buy	+1,160	New	+$922K	0.01%	119
2020 Q4	–	Sell	-135	Closed	-$161K	–	115
2020 Q3	$161K	Buy	+135	New	+$150K	0.01%	101

Other funds holding GOVX

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return

Armistice Capital's GOVX Position: Q2 2026 in Review

Armistice Capital sold out of GeoVax Labs (GOVX) in Q2 2026, closing a stake of 269,253 shares — an estimated $372K sold.

Armistice Capital first reported a position in GOVX in Q3 2020 and held it in 9 quarters. The position peaked at $1.13M in Q2 2022. 17 funds tracked by Wall St. Rank hold GOVX as of Q2 2026.

Armistice Capital reported no remaining GeoVax Labs position as of Q2 2026 after selling out during the quarter.
Armistice Capital sold 269,253 GeoVax Labs shares in Q2 2026, an estimated $372K.
Armistice Capital first reported a position in GeoVax Labs in Q3 2020 and held it in 9 quarters.
Armistice Capital's GeoVax Labs position peaked at $1.13M in Q2 2022.
17 funds tracked by Wall St. Rank held GeoVax Labs as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.